Tabuk Makes MENA Deal For Prestige’s Trastuzumab

Pair Strike Agreement On Rights To Tuznue Biosimilar To Herceptin

 
• By Dave Wallace

Saudi firm Tabuk has struck a deal to sell Prestige BioPharma’s Tuznue trastuzumab biosimilar in the MENA region.

MENA Map At Night
The deal gives Tabuk rights to Prestige’s trastuzumab in the MENA region • Source: Shutterstock

More from Deals

More from Business